Literature DB >> 23620159

Acid-detoxified Inaba lipopolysaccharide (pmLPS) is a superior cholera conjugate vaccine immunogen than hydrazine-detoxified lipopolysaccharide and induces vibriocidal and protective antibodies.

Cyrille Grandjean1, Terri K Wade, David Ropartz, Logan Ernst, William F Wade.   

Abstract

Worldwide, in endemic areas of cholera, the group most burdened with cholera is children. This is especially vexing as young children (2-5 years of age) do not respond as well, or for as long as adults do, to the current killed oral cholera vaccines (OCV). Conjugate vaccines based on the hapten-carrier paradigm have been developed for several bacterial pathogens that cause widespread and severe diseases in young children. We and others have studied different formulations of Vibrio cholerae (Vc) O1 lipopolysaccharide (LPS, a T-independent antigen) conjugates. Detoxified LPS is a central component of a LPS-based conjugate vaccine. pmLPS, which is detoxified by acid treatment, is a superior immunogen compared with hydrazine-detoxified LPS (DetAcLPS) that has altered lipid A acyl chains. The other feature of pmLPS is the ability to link carrier proteins to a core region of sugar. pmLPS readily induced vibriocidal antibodies following one intraperitoneal dose in a MPL-type adjuvant One dose of the pmLPS conjugate was suggestive of being protective; a booster resulted in protective antibodies for infant mice challenged with virulent cholera.
© 2013 Federation of European Microbiological Societies. Published by Blackwell Publishing Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23620159     DOI: 10.1111/2049-632X.12022

Source DB:  PubMed          Journal:  Pathog Dis        ISSN: 2049-632X            Impact factor:   3.166


  2 in total

1.  On the use of adenovirus dodecahedron as a carrier for glycoconjugate vaccines.

Authors:  Maruthi Prasanna; Malgorzata Podsiadla-Bialoskorska; Damian Mielecki; Nicolas Ruffier; Amina Fateh; Annie Lambert; Mathieu Fanuel; Emilie Camberlein; Ewa Szolajska; Cyrille Grandjean
Journal:  Glycoconj J       Date:  2021-04-14       Impact factor: 2.916

2.  Evaluation in mice of a conjugate vaccine for cholera made from Vibrio cholerae O1 (Ogawa) O-specific polysaccharide.

Authors:  Mohammad Murshid Alam; Megan Kelly Bufano; Peng Xu; Anuj Kalsy; Y Yu; Y Wu Freeman; Tania Sultana; Md Rasheduzzaman Rashu; Ishaan Desai; Grace Eckhoff; Daniel T Leung; Richelle C Charles; Regina C LaRocque; Jason B Harris; John D Clements; Stephen B Calderwood; Firdausi Qadri; W F Vann; Pavol Kováč; Edward T Ryan
Journal:  PLoS Negl Trop Dis       Date:  2014-02-06
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.